#Stocks2Watch: FOX Business rounds up the stocks you should watch before the opening bell rings on Wall Street. Tweet @adamsamson or e-mail email@example.com and tell us what stocks you're watching -- your picks could appear online!
GlaxoSmithKline (GSK) said its experimental cancer vaccine failed in a trial of patients who had lung cancer. This marks the second time the therapy didn't work as planned, after Glaxo's drug didn't meet its goals in those with melanoma. As opposed to a normal vaccine that looks to prevent diseases, this one is meant to help people who have already had cancer fight-off a recurrence. The drug giant said it's still looking for sub-groups that will be positively impacted by the vaccine.
The shares are down about 2%.
2Synta Pharmaceuticals (SNTA)
Synta Pharmaceuticals (SNTA) unveiled positive interim results from its ENCHANT-1 trial for a drug candidate called ganetespib that aims to help those with certain types of metastatic breast cancer. The pharma company said the results "warrant expanded study of ganetespib in this metastatic disease setting."
The shares are spiking more than 20%.
3ConAgra Foods (CAG)
ConAgra Foods (CAG) unveiled profits that narrowly beat trimmed-down estimates and sales that were essentially in-line with Street views. Shares of the company that makes consumer products like Slim Jim jerky and Chef Boyardee pastas are climbing 2%.
FOX Business News Editor / Reporter Victoria Craig says she's watching shares of big banks.
The Federal Reserve is set to release its most recent stress tests on large banks on the day. The tests on companies like JPMorgan Chase (JPM), Bank of America (BAC), Citigroup (C) and Wells Fargo (WFC) create hypothetical worst-case scenarios where the economy slows sharply, unemployment spikes and the financial market seizes up.
5Jabil Circuit (JBL)